Australian Resources

Table of Contents

Downloadable materials

Crysvita® Resources

XLH Resources

XLH Disease Mechanism

Symposium Highlights

Videos

Cameron’s story

The next chapter
AU-CRV-23-00006 JUL2023

ANZBMS Case Study – Prof Rory Clifton-Bligh

ANZBMS Case Study – A.Prof Christian Girgis

ANZBMS 2023 Kyowa Kirin Australia Symposium – The Australian Crysvita XLH Experience

ANZBMS 2022 – Kyowa Kirin Symposium – Introducing a new era in the management of XLH

(Full Symposium incl. Q&A)

Expert Opinion Video – XLH & CRYSVITA® (burosumab)

Cameron’s story

The next chapter
AU-CRV-23-00006 JUL2023

ANZBMS Case Study – Prof Rory Clifton-Bligh

ANZBMS Case Study – A.Prof Christian Girgis

ANZBMS 2023 Kyowa Kirin Australia Symposium – The Australian Crysvita XLH Experience

ANZBMS 2022 – Kyowa Kirin Symposium – Introducing a new era in the management of XLH

(Full Symposium incl. Q&A)

ANZBMS 2022 – Kyowa Kirin Symposium – Part 1

XLH – Looking back, looking forward

ANZBMS 2022 – Kyowa Kirin Symposium – Part 2

The safety and efficacy of CRYSVITA® (burosumab) in paediatrics

ANZBMS 2022 – Kyowa Kirin Symposium – Part 3

The safety and efficacy of CRYSVITA® (burosumab) in adults

Expert Opinion Video – XLH & CRYSVITA® (burosumab)

Podcasts

Management of adult patients with XLH – A/Prof Peter Simm with Dr Penny Coates

Publications of interest

Publicly Available Websites

Publicly Available Websites

XLH information websites for healthcare professionals

1. XLHLink.asia (Healthcare professional website)
https://www.xlhlink.asia/hcp/
This website is developed and funded by Kyowa Kirin Asia Pacific Pte. Ltd.

1. The Australian Bone and Mineral Society (ANZBMS)
https://www.anzbms.org.au/

2. The Australasian Paediatric Endocrine Group (ANZSPED)
https://anzsped.org/ /

3. The Australian and New Zealand Society of Nephrology (ANZSN)
https://nephrology.edu.au/

XLH Information websites for patients

1. XLHLink.asia (Patient website)
https://www.xlhlink.com.au/patientstories/
This website is developed and funded by Kyowa Kirin Australia Pty. Ltd.

2. XLH Australia Incorporated
https://xlhaustralia.com/

3. Rare Voices Australia
https://rarevoices.org.au/

We are not affiliated, associated, authorised, endorsed by, or in any way officially connected with any other company, agency or government agency listed hereunder or otherwise.

1. Beck-Nielsen SS, et al. Eur J Endocrinol. 2009;160:491–7. 2. Endo I, et al. Endocr J. 2015;62:811–6. 3. Carpenter TO, et al. J Bone Miner Res. 2011;26:1381–8. 4. Haffner D, et al. Nat Rev Nephrol. 2019;15:435–55. 5. Rafaelsen S, et al. Eur J Endocrinol. 2016;174:125–36. 6. Rajah J, et al. Eur J Pediatr. 2011;170:1089–96. 7. Raimann A, et al. Wien Med Wochenschr. 2020;170:116–23. 8. Razzaque MS. Nat Rev Endocrinol. 2009;5:611–9. 9. Linglart A, et al. Endocr Connect. 2014;3:R13–30. 10. Beck-Nielsen SS, et al. Orphanet J Rare Dis. 2019;14:58. 11. CRYSVITA® (burosumab). Based on Singapore Package Insert. Kyowa Kirin Asia Pacific Pte Ltd; May 2021. 12. Portale AA, et al. Calcif Tissue Int. 2019;105:271–84. 13. Imel EA, et al. Lancet. 2019;393:2416–27. 14. Insogna KL, et al. J Bone Miner Res. 2019;34:2183–91. 15. Carpenter TO, et al. N Eng J Med. 2018;378:1987–98. 16. Insogna KL, et al. J Bone Miner Res. 2018;33:1383–93

References